InvestorsHub Logo

misiu143

04/17/17 8:47 PM

#13648 RE: Amatuer17 #13647


Maybe because P 3 combo is for HAART resistant patients , estimate to be about 25,000 in USA , possibly FDA includes also patients with bad sides effects to HAART so they came with number of over 200,000 patients just for this study .

Well , imo it is good for CYDY .
I am just surprise why it took FDA such a long time to make this decision !!!

The Lawman

04/17/17 11:19 PM

#13652 RE: Amatuer17 #13647

My guess, A17, is that Pourhassan hoped to get ODD for GVHD.

It appears, however, that the application to the FDA was not presented that way.

Another botched FDA application that can be laid at the feet of the esteemed "Dr." Pourhassan.

Hopefully, we have heard the last of the good doctor as he hands over the reigns to Tony C.

LM